These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4844244)

  • 1. Assessment of tolerance to the hallucinogenic effects of DOM.
    Angrist B; Rotrosen J; Gershon S
    Psychopharmacologia; 1974 Apr; 36(3):203-7. PubMed ID: 4844244
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of fenfluramine, 2,5-dimethoxy-4-methyl amphetamine (DOM) and D-amphetamine on the concentration of serotonin and some free amino acids in the suboesophageal ganglia of Helix pomatia.
    Osborne NN; Neuhoff V; Leonard BE
    Z Naturforsch C Biosci; 1974; 29(3):189-90. PubMed ID: 4276702
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
    Buyniski JP; Smith ML; Bierwagen ME
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236
    [No Abstract]   [Full Text] [Related]  

  • 4. Scratching response induced in mice by mescaline and related amphetamine derivatives.
    Kulkarni AS
    Biol Psychiatry; 1973 Apr; 6(2):177-80. PubMed ID: 4709133
    [No Abstract]   [Full Text] [Related]  

  • 5. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
    Otaka T
    Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.
    Penington NJ; Reiffenstein RJ
    Eur J Pharmacol; 1986 Apr; 122(3):373-7. PubMed ID: 3709659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin.
    Huang JT; Ho BT
    Can J Physiol Pharmacol; 1973 Dec; 51(12):976-80. PubMed ID: 4777246
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular effects of 2,5-dimethoxy-4-methyl amphetamine (S.T.P. or D.O.M.)].
    Boissier JR; Advenier C; Giudicelli JF
    Therapie; 1972; 27(6):989-99. PubMed ID: 4661229
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of 2,5-dimethoxy-4-methylamphetamine on heart and smooth muscle contraction.
    Huang JT; Ho BT
    J Pharm Pharmacol; 1974 Jan; 26(1):69-70. PubMed ID: 4150941
    [No Abstract]   [Full Text] [Related]  

  • 10. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
    Snyder SH; Faillace L; Hollister L
    Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific requirements for hallucinogenesis.
    Shulgin AT
    J Pharm Pharmacol; 1973 Mar; 25(3):271-2. PubMed ID: 4146335
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF
    J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
    [No Abstract]   [Full Text] [Related]  

  • 14. DOM (STP), a new hallucinogenic drug, and DOET: effects in normal subjects.
    Snyder SH; Faillace LA; Weingartner H
    Am J Psychiatry; 1968 Sep; 125(3):113-20. PubMed ID: 4385937
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
    Adams LM; Geyer MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Spüler M; Nichols DE
    Psychopharmacology (Berl); 1989; 98(3):297-303. PubMed ID: 2568652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus.
    Winter JC
    Psychopharmacologia; 1975 Oct; 44(1):29-32. PubMed ID: 1197576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
    Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
    J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
    Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
    Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.